Atea Pharmaceuticals
AVIR
AVIR
112 hedge funds and large institutions have $220M invested in Atea Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.93% less ownership
Funds ownership: 66.51% → 64.58% (-1.9%)
13% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 39
92% less call options, than puts
Call options by funds: $494K | Put options by funds: $6.38M
Holders
112
Holding in Top 10
1
Calls
$494K
Puts
$6.38M
Top Buyers
| 1 | +$1.73M | |
| 2 | +$1.41M | |
| 3 | +$1.17M | |
| 4 |
Two Sigma Advisers
New York
|
+$1.04M |
| 5 |
Two Sigma Investments
New York
|
+$850K |
Top Sellers
| 1 | -$3.43M | |
| 2 | -$2.56M | |
| 3 | -$1.66M | |
| 4 |
Renaissance Technologies
New York
|
-$1.51M |
| 5 |
BlackRock
New York
|
-$810K |